Oric Pharmaceuticals ORIC
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 12.00 | 112.53 | -0.33 | -36,671 | -33 | |
| 2025Q2 | 10.15 | 107.45 | -0.47 | -39,064 | -36 | |
| 2025Q1 | 5.58 | 108.98 | -0.42 | -32,718 | -30 | |
| 2024Q4 | 8.07 | 108.99 | -0.51 | -39,570 | -36 | |
| 2024Q3 | 10.25 | 110.85 | -0.49 | -38,318 | -35 | |
| 2024Q2 | 7.07 | 112.68 | -0.46 | -36,017 | -32 | |
| 2024Q1 | 13.75 | 115.91 | -0.37 | -28,990 | -25 | |
| 2023Q4 | 9.20 | 110.94 | -0.50 | -31,428 | -28 | |
| 2023Q3 | 6.05 | 112.58 | -0.43 | -28,682 | -25 | |
| 2023Q2 | 7.76 | 108.93 | -0.50 | -24,992 | -23 | |
| 2023Q1 | 5.70 | 107.24 | -0.53 | -25,678 | -24 | |
| 2022Q4 | 5.89 | 106.10 | -0.52 | -22,119 | -21 | |
| 2022Q3 | 3.20 | 103.48 | -0.63 | -25,694 | -25 | |
| 2022Q2 | 4.48 | 102.02 | -0.51 | -20,696 | -20 | |
| 2022Q1 | 5.34 | 100.43 | -0.59 | -23,258 | -23 | |
| 2021Q4 | 14.70 | 100.15 | -0.58 | -22,805 | -23 | |
| 2021Q3 | 20.91 | 100.16 | -0.47 | -18,456 | -18 | |
| 2021Q2 | 17.69 | 100.23 | -0.57 | -21,057 | -21 | |
| 2021Q1 | 24.50 | 100.27 | -0.45 | -16,553 | -17 | |
| 2020Q4 | 33.85 | 100.08 | -0.84 | -28,282 | -28 |